Back to top
more

PRESTIGE CONSMR (PBH)

(Delayed Data from NYSE)

$70.00 USD

70.00
223,436

-1.26 (-1.77%)

Updated May 3, 2024 04:00 PM ET

After-Market: $69.96 -0.04 (-0.06%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value D Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (151 out of 252)

Industry: Medical - Products

Better trading starts here.

Zacks News

Prestige Consumer (PBH) Brands & E-commerce Strength Bode Well

Prestige Consumer Healthcare's (PBH) solid brand portfolio and e-commerce growth keep the company well-placed.

PVH Corp (PVH) Q2 Earnings Top Estimates, Dip Y/Y on Inflation

PVH Corp's (PVH) Q2 results are hurt by supply-chain issues and inflation. However, brand strength, particularly Calvin Klein and Tommy Hilfiger, and gains from the PVH+ Plan bode well.

Down 12.1% in 4 Weeks, Here's Why Prestige Brands (PBH) Looks Ripe for a Turnaround

Prestige Brands (PBH) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

Guess? (GES) Q2 Earnings Lag Estimates, Revenues Grow Y/Y

Guess?'s (GES) second-quarter fiscal 2023 results reflect higher sales, backed by increases in most segments. However, earnings and adjusted operating margin decline year over year.

Prestige Brands (PBH) Moves to Buy: Rationale Behind the Upgrade

Prestige Brands (PBH) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

PBH vs. VZIO: Which Stock Should Value Investors Buy Now?

PBH vs. VZIO: Which Stock Is the Better Value Option?

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Prestige Consumer (PBH) Q1 Earnings Top Estimates, Revenues Up

Prestige Consumer Healthcare's (PBH) first-quarter fiscal 2023 results reflect increased revenues thanks due to strength in key brands, while earnings decline year over year.

Prestige Brands (PBH) Beats Q1 Earnings and Revenue Estimates

Prestige Brands (PBH) delivered earnings and revenue surprises of 5.83% and 3.31%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Prestige Consumer (PBH) Queued for Q1 Earnings: Things to Note

Prestige Consumer's (PBH) first-quarter fiscal 2023 performance will likely reflect the impacts of escalated inflationary environment and supply-chain issues.

Prestige Consumer (PBH) Brand-Building Efforts Solid, Costs High

Prestige Consumer (PBH) is benefiting from its solid brand-building efforts and growing e-commerce business.

Prestige Consumer (PBH) Stock Up on Q4 Earnings & Revenue Beat

Prestige Consumer's (PBH) fourth-quarter results benefit from strong consumer demand and strength in certain categories that were earlier affected by the pandemic.

Prestige Brands (PBH) Tops Q4 Earnings and Revenue Estimates

Prestige Brands (PBH) delivered earnings and revenue surprises of 2.25% and 3.38%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Central Garden (CENT) Q2 Earnings and Revenues Beat Estimates

Central Garden (CENT) delivered earnings and revenue surprises of 7.63% and 2.06%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

What's in Store for Prestige Consumer (PBH) in Q4 Earnings?

Prestige Consumer's (PBH) fourth-quarter results are likely to reflect high demand for certain categories and gains from buyouts, while high costs are a concern.

Prestige Consumer (PBH) Hurt by High Costs, Solid Demand Aids

Prestige Consumer Healthcare (PBH) is battling elevated cost and supply-chain challenges, while domestic consumer healthcare demand for certain categories has been aiding the company.

Prestige Consumer (PBH) Well Poised on Solid Brand, E-Commerce

Prestige Consumer Healthcare (PBH) has been gaining on its robust brand portfolio. Prudent acquisitions and e-commerce strength are working well for the company.

What Makes Prestige Brands (PBH) a New Buy Stock

Prestige Brands (PBH) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Prestige Consumer (PBH) Rises on Q3 Earnings Beat, Raised View

Prestige Consumer's (PBH) third-quarter results benefit from strong consumer demand and the strength in certain categories that were earlier affected by the pandemic. Management ups fiscal 2022 view.

Prestige Brands (PBH) Beats Q3 Earnings and Revenue Estimates

Prestige Brands (PBH) delivered earnings and revenue surprises of 11.24% and 5.57%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Factors to Know Ahead of Prestige Consumer (PBH) Q3 Earnings

Gains from brand-building strategies, e-commerce operations and buyouts might contribute to Prestige Consumer's (PBH) third-quarter fiscal 2022 results.

Prestige Brands (PBH) Reports Next Week: Wall Street Expects Earnings Growth

Prestige Brands (PBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Should Value Investors Consider Prestige (PBH) Stock Now?

Let's see if Prestige (PBH) stock is a good choice for value-oriented investors right now from multiple angles.

Prestige Consumer (PBH) Tops Q2 Earnings & Revenue Estimates

Prestige Consumer's (PBH) Q2 results reflect gains from solid demand and continued recovery in certain categories. Encouragingly, it raises the fiscal 2022 guidance.

Prestige Brands (PBH) Beats Q2 Earnings and Revenue Estimates

Prestige Brands (PBH) delivered earnings and revenue surprises of 3.03% and 5.71%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?